Use of a phycoerythrin-conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry
P. Lloyd-evans et al., Use of a phycoerythrin-conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry, TRANSFUS M, 9(2), 1999, pp. 155-160
The use of flow cytometry for quantifying fetomaternal haemorrhage is incre
asing, and has been shown to be more accurate than the Kleihauer-Betke test
for evaluating larger bleeds of over 4 mL in volume. Red cells are stained
with fluorescently labelled monoclonal anti-D. Cells for analysis are norm
ally gated manually on the basis of forward and side scatter. We investigat
ed whether the use of an antiglycophorin A monoclonal antibody conjugate (r
ed cell specific) in a dual labelling technique would improve the gating of
RBC and FMH quantification.
Mixes of adult rr and cord R(1)r RBC were prepared to simulate 1, 0.5, 0.25
, 0.12 and 0.06% fetal bleeds. Phycoerythrin-conjugated BRIC 256 (mouse mon
oclonal antiglycophorin A) was used to label all RBC, and FITC-BRAD-3 monoc
lonal anti-D was used to determine the proportion of D-positive cells. Resu
lts from the dual labelling experiments were compared to those from single
labelling of the same mixtures with FITC-BRAD-3 alone, using gated and unga
ted data. The results showed that single labelling with manual gating gave
falsely low FMH estimates.
We conclude that use of a fluorescently labelled antiglycophorin A antibody
improves the accuracy of the FMH measurement by flow cytometry, as manual
subjective gating of RBC excludes a higher proportion of fetal than of adul
t RBC.